Search results
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 1 day agoModerna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received US Food and Drug...
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 7 days agoFood and Drug Administration has approved Moderna's respiratory syncytial virus vaccine, the company...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 2 days agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
Moderna's RSV Vaccine Approved by FDA
Medscape· 4 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
Moderna’s vaccine for RSV gets FDA approval for people 60 and older - The Boston Globe
The Boston Globe· 7 days agoModerna said Friday that US drug regulators have approved its second product, a vaccine for...
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 7 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
Morningstar· 1 day agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support ...
FDA Green-Lights Moderna Vaccine for Older Adults | Newswise
Newswise· 1 day agoThe US Food and Drug Administration has approved Moderna’s mRNA vaccine for older adults to protect against respiratory syncytial virus (RSV). According ...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 4 days ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
Moderna Drug Candidate Tapped for FDA Rare-Disease Pilot Program
Morningstar· 1 day agoBy Colin Kellaher Moderna's mRNA-3705 drug candidate for a rare, genetic disorder of the liver has been chosen for a Food and Drug Administration pilot program aimed at addressing ...